News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Immuron.
RELATED STOCKHEAD STORIES
News
ASX stocks in America: Opthea’s about to join the ranks but who’s there already?
Health & Biotech
The 6 ASX small cap biotechs that have more than doubled in 2020
Health & Biotech
Dr Boreham’s Crucible: Dimerix not putting all its eggs in one basket
Experts
Scopo’s powerplays: It just won’t go down!
News
Weekly ASX small cap wrap: Who’s (literally) sinking the boat this week?
Health & Biotech
Check up: COVID-19 is back in fashion
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: What does a trillion dollars look like?
Health & Biotech
Imagion tech brings down Tesla
News
10 at 10: These ASX stocks are skating on this morning
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who’s getting an extension today?
Health & Biotech
Immuron’s diarrhoea drug may help treat COVID-19; investors get excited
Health & Biotech
Check up: Diarrhoea and the FDA are lifting share prices
News
Weekly ASX Small Cap Wrap: Who’s blundering around in the dark this week?
News
10 at 10: These ASX stocks are swinging swords this morning
News
